Percutaneous Coronary Intervention
Showing 26 - 50 of >10,000
Coronary Artery Disease Trial (Routine Angiography Follow-up, Routine Clinical Follow-up)
Not yet recruiting
- Coronary Artery Disease
- Routine Angiography Follow-up
- Routine Clinical Follow-up
- (no location specified)
Jun 20, 2023
Stable Angina, Chronic Total Occlusion of Coronary Artery Trial in Basildon, Bournemouth (Percutaneous coronary intervention,
Recruiting
- Stable Angina
- Chronic Total Occlusion of Coronary Artery
- Percutaneous coronary intervention
- Placebo percutaneous coronary intervention
-
Basildon, Essex, United Kingdom
- +1 more
Jan 23, 2023
Percutaneous Coronary Intervention Optimization With Fractional
Completed
- Coronary Artery Disease
- +2 more
- IVUS guided PCI optimization
- +2 more
- (no location specified)
Feb 19, 2023
High-Risk Percutaneous Coronary Intervention Trial (Impella ECP)
Recruiting
- High-Risk Percutaneous Coronary Intervention
- Impella ECP
-
Detroit, MichiganAscension St. John Hospital
Dec 23, 2022
ST-segment Elevation Myocardial Infarction (STEMI), Total Occlusion of Coronary Artery, Primary Percutaneous Coronary
Not yet recruiting
- ST-segment Elevation Myocardial Infarction (STEMI)
- +2 more
- Export Catheter
- Balloon catheter
- (no location specified)
Aug 19, 2022
Coronary Artery Chronic Total Occlusion Scoring Systems
Recruiting
- Chronic Total Occlusion of Coronary Artery
- percutaneous coronary intervention
-
Taipei, TaiwanNational Taiwan University Hospital
May 31, 2023
Percutaneous Coronary Intervention, Coronary Heart Disease, Robotic Surgical Procedures Trial (ALLVAS® robotic-assisted PCI)
Not yet recruiting
- Percutaneous Coronary Intervention
- +2 more
- ALLVAS® robotic-assisted PCI
- (no location specified)
Dec 7, 2022
Coronary Artery Disease Trial in Helwan (Colchicine 0.5 MG Oral Tablet, Placebo)
Not yet recruiting
- Coronary Artery Disease
- Colchicine 0.5 MG Oral Tablet
- Placebo
-
Helwan, Cairo, EgyptHelwan University Hospital
Feb 13, 2023
STEMI, Multi Vessel Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Xiamen (In-hospital staged PCI,
Recruiting
- STEMI
- +2 more
- In-hospital staged PCI
- Out-hospital staged PCI
-
Xiamen, Fujian, ChinaXiamen Cardiovascular Hospital Xiamen University
Oct 29, 2022
High-Risk Percutaneous Coronary Intervention Trial in Tbilisi (The Elevate™ System)
Active, not recruiting
- High-Risk Percutaneous Coronary Intervention
- The Elevate™ System
-
Tbilisi, GeorgiaIsraeli-Georgian Medical Research Clinic "Helsicore"
Oct 24, 2023
ST-segment Elevation Myocardial Infarction (STEMI) Trial (No aspirin (Prasugurel monotherapy), 12-month DAPT)
Not yet recruiting
- ST-segment Elevation Myocardial Infarction (STEMI)
- No aspirin (Prasugurel monotherapy)
- 12-month DAPT
- (no location specified)
Feb 1, 2023
Rivaroxaban - Percutaneous Coronary Intervention
Completed
- Coronary Artery Disease
- Atrial Fibrillation
- In vitro heparin
-
Bursa, TurkeyBursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi
Sep 13, 2022
ST Elevation Myocardial Infarction Trial in Netherlands (Ticagrelor, Aspirin)
Recruiting
- ST Elevation Myocardial Infarction
-
Alkmaar, Netherlands
- +4 more
Aug 3, 2023
Obesity Trial in Lincoln (MOMENTUM)
Completed
- Obesity
- MOMENTUM
-
Lincoln, NebraskaBryanLGH Medical Center
Sep 28, 2022
Patients Undergoing Percutaneous Coronary Procedures
Not yet recruiting
- Coronary Artery Disease
- Coronary angiography and percutaneous coronary intervention
- (no location specified)
Nov 23, 2022
Myocardial Infarction Trial in Sheffield (Enoxaparin)
Completed
- Myocardial Infarction
-
Sheffield, South Yorkshire, United KingdomSheffield Teaching Hospitals NHS Foundation Trust
Nov 10, 2022
Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Percutaneous Coronary Intervention Trial in Falls Church
Terminated
- Diabetes Mellitus, Type 2
- +2 more
- Evolocumab
- Placebo
-
Falls Church, VirginiaInova Fairfax Hospital
Dec 22, 2022
Atrial Fibrillation, Acute Coronary Syndrome Trial in Ottawa (Ticagrelor, Rivaroxaban)
Active, not recruiting
- Atrial Fibrillation
- Acute Coronary Syndrome
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Jan 12, 2023
Percutaneous Coronary Intervention, Hemostasis Trial in Beijing (Experimental: Low pressure group of quantitative pressure
Not yet recruiting
- Percutaneous Coronary Intervention
- Hemostasis
- Experimental: Low pressure group of quantitative pressure patent hemostasis
- +3 more
-
Beijing, ChinaPeking University First Hospital
Mar 16, 2023
Coronary Artery Disease, Distal Radial Artery, Complex Intervention Trial in Yongin (Percutaneous coronary intervention via the
Recruiting
- Coronary Artery Disease
- +2 more
- Percutaneous coronary intervention via the snuffbox approach
-
Yongin, Gyeonggi-do, Korea, Republic of
- +1 more
Nov 7, 2022
Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Coronary Artery Disease Trial in Bern (Algorithm-guided
Not yet recruiting
- Percutaneous Coronary Intervention
- +2 more
- Algorithm-guided DAPT duration
- Standard-of-care DAPT duration
-
Bern, SwitzerlandBern University Hospital
Feb 16, 2023
IHD, LV Dysfunction Trial in Copenhagen (PCI, CABG)
Not yet recruiting
- IHD
- LV Dysfunction
- PCI
- CABG
-
Copenhagen, DenmarkRigshospitalet, University of Copenhagen
Sep 11, 2022
Coronary Heart Disease, Percutaneous Coronary Intervention, Depression Trial in Nanjing (percutaneous coronary intervention)
Active, not recruiting
- Coronary Heart Disease
- +2 more
- percutaneous coronary intervention
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Mar 26, 2022
Percutaneous Coronary Intervention Trial in Napoli (Cangrelor)
Recruiting
- Percutaneous Coronary Intervention
-
Napoli, ItalyUniversity Federico II of Naples
Jul 25, 2022
Myocardial Infarction Trial (primary percutaneous intervention)
Not yet recruiting
- Myocardial Infarction
- primary percutaneous intervention
- (no location specified)
Oct 25, 2022